Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2623 entries
Sorted by: Best Match Show Resources per page
Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report.

Journal of medical case reports

Cheungpasitporn W, Jirajariyavej T, Howarth CB, Rosen RM.
PMID: 21831272
J Med Case Rep. 2011 Aug 10;5:364. doi: 10.1186/1752-1947-5-364.

INTRODUCTION: Henoch-Schönlein purpura is the most common systemic vasculitis in children. Typical presentations are palpable purpura, abdominal pain, arthritis, and hematuria. This vasculitic syndrome can present as an uncommon cause of rectal bleeding in older patients. We report a...

Cite
Cheungpasitporn W, Jirajariyavej T, Howarth CB, et al. Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report. J Med Case Rep. 2011;5:364doi: 10.1186/1752-1947-5-364.
Cheungpasitporn, W., Jirajariyavej, T., Howarth, C. B., & Rosen, R. M. (2011). Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report. Journal of medical case reports, 5364. https://doi.org/10.1186/1752-1947-5-364
Cheungpasitporn, Wisit, et al. "Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report." Journal of medical case reports vol. 5 (2011): 364. doi: https://doi.org/10.1186/1752-1947-5-364
Cheungpasitporn W, Jirajariyavej T, Howarth CB, Rosen RM. Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report. J Med Case Rep. 2011 Aug 10;5:364. doi: 10.1186/1752-1947-5-364. PMID: 21831272; PMCID: PMC3163221.
Copy Download .nbib Format: NLM
Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease.

Journal of clinical & experimental ophthalmology

Rivera-Grana E, Lin P, Suhler EB, Rosenbaum JT.
PMID: 26807304
J Clin Exp Ophthalmol. 2015 Apr;6(2). doi: 10.4172/2155-9570.1000422. Epub 2015 Apr 27.

OBJECTIVE: Thyroid eye disease (TED) is generally treated with oral corticosteroid therapy. A steroid sparing drug could be a useful adjunct. We reviewed our experience with methotrexate as a corticosteroid sparing agent to treat TED.METHODS: Retrospective chart review from...

Cite
Rivera-Grana E, Lin P, Suhler EB, et al. Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease. J Clin Exp Ophthalmol. 2015;6(2)doi: 10.4172/2155-9570.1000422.
Rivera-Grana, E., Lin, P., Suhler, E. B., & Rosenbaum, J. T. (2015). Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease. Journal of clinical & experimental ophthalmology, 6(2), . https://doi.org/10.4172/2155-9570.1000422
Rivera-Grana, Erick, et al. "Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease." Journal of clinical & experimental ophthalmology vol. 6,2 (2015). doi: https://doi.org/10.4172/2155-9570.1000422
Rivera-Grana E, Lin P, Suhler EB, Rosenbaum JT. Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease. J Clin Exp Ophthalmol. 2015 Apr;6(2). doi: 10.4172/2155-9570.1000422. Epub 2015 Apr 27. PMID: 26807304; PMCID: PMC4718577.
Copy Download .nbib Format: NLM
Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis.

Case reports in endocrinology

Lithgow K, Symonds C.
PMID: 28912982
Case Rep Endocrinol. 2017;2017:2683120. doi: 10.1155/2017/2683120. Epub 2017 Aug 24.

A 73-year-old male on home peritoneal dialysis (PD) with recent diagnosis of atrial fibrillation presented with fatigue and dyspnea. Hyperthyroidism was diagnosed with TSH < 0.01 mIU/L and FT4 > 100 pmol/L. He had no personal or family history...

Cite
Lithgow K, Symonds C. Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis. Case Rep Endocrinol. 2017;2017:2683120doi: 10.1155/2017/2683120.
Lithgow, K., & Symonds, C. (2017). Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis. Case reports in endocrinology, 20172683120. https://doi.org/10.1155/2017/2683120
Lithgow, Kirstie, and Symonds, Christopher. "Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis." Case reports in endocrinology vol. 2017 (2017): 2683120. doi: https://doi.org/10.1155/2017/2683120
Lithgow K, Symonds C. Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis. Case Rep Endocrinol. 2017;2017:2683120. doi: 10.1155/2017/2683120. Epub 2017 Aug 24. PMID: 28912982; PMCID: PMC5587962.
Copy Download .nbib Format: NLM
Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient.

Journal of nephropathology

Ventura Aguiar P, Dias C, Azevedo P, Silva HN, Almeida M, Pedroso S, Martins LS, Dias L, Rodrigues A, Viscaíño R, Cabrita A, Henriques AC.
PMID: 26312238
J Nephropathol. 2015 Jul;4(3):97-100. doi: 10.12860/jnp.2015.18. Epub 2015 Jul 01.

BACKGROUND: Histiocytic sarcoma (HS) is a rare hematologic neoplasm with a few hundred cases having been described to date.CASE PRESENTATION: We report the case of a 56-year-old woman with a history of hepatitis C infection and chronic kidney disease...

Cite
Ventura Aguiar P, Dias C, Azevedo P, et al. Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient. J Nephropathol. 2015;4(3):97-100doi: 10.12860/jnp.2015.18.
Ventura Aguiar, P., Dias, C., Azevedo, P., Silva, H. N., Almeida, M., Pedroso, S., Martins, L. S., Dias, L., Rodrigues, A., Viscaíño, R., Cabrita, A., & Henriques, A. C. (2015). Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient. Journal of nephropathology, 4(3), 97-100. https://doi.org/10.12860/jnp.2015.18
Ventura Aguiar, Pedro, et al. "Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient." Journal of nephropathology vol. 4,3 (2015): 97-100. doi: https://doi.org/10.12860/jnp.2015.18
Ventura Aguiar P, Dias C, Azevedo P, Silva HN, Almeida M, Pedroso S, Martins LS, Dias L, Rodrigues A, Viscaíño R, Cabrita A, Henriques AC. Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient. J Nephropathol. 2015 Jul;4(3):97-100. doi: 10.12860/jnp.2015.18. Epub 2015 Jul 01. PMID: 26312238; PMCID: PMC4544561.
Copy Download .nbib Format: NLM
Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?.

PLoS currents

Buckon C, Sienko S, Bagley A, Sison-Williamson M, Fowler E, Staudt L, Heberer K, McDonald CM, Sussman M.
PMID: 27500011
PLoS Curr. 2016 Jul 08;8. doi: 10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0.

BACKGROUND: In the absence of a curative treatment for Duchenne Muscular Dystrophy (DMD), corticosteroid therapy (prednisone, deflazacort) has been adopted as the standard of care, as it slows the progression of muscle weakness and enables longer retention of functional...

Cite
Buckon C, Sienko S, Bagley A, et al. Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?. PLoS Curr. 2016;8doi: 10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0.
Buckon, C., Sienko, S., Bagley, A., Sison-Williamson, M., Fowler, E., Staudt, L., Heberer, K., McDonald, C. M., & Sussman, M. (2016). Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?. PLoS currents, 8. https://doi.org/10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0
Buckon, Cathleen, et al. "Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?." PLoS currents vol. 8 (2016). doi: https://doi.org/10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0
Buckon C, Sienko S, Bagley A, Sison-Williamson M, Fowler E, Staudt L, Heberer K, McDonald CM, Sussman M. Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?. PLoS Curr. 2016 Jul 08;8. doi: 10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0. PMID: 27500011; PMCID: PMC4956479.
Copy Download .nbib Format: NLM
Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report.

Journal of neurological surgery reports

Sakai N, Ito-Yamashita T, Takahashi G, Baba S, Koizumi S, Yamasaki T, Tokuyama T, Namba H.
PMID: 25083392
J Neurol Surg Rep. 2014 Aug;75(1):e62-6. doi: 10.1055/s-0033-1363505. Epub 2014 Jan 16.

Primary neurolymphomatosis is an extremely rare tumor. We report the case of a 74-year-old patient presenting with dysphagia and hoarseness. Initial contrast-enhanced computed tomography of the head, neck, and chest did not reveal any lesions. His symptoms improved with...

Cite
Sakai N, Ito-Yamashita T, Takahashi G, et al. Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report. J Neurol Surg Rep. 2014;75(1):e62-6doi: 10.1055/s-0033-1363505.
Sakai, N., Ito-Yamashita, T., Takahashi, G., Baba, S., Koizumi, S., Yamasaki, T., Tokuyama, T., & Namba, H. (2014). Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report. Journal of neurological surgery reports, 75(1), e62-6. https://doi.org/10.1055/s-0033-1363505
Sakai, Naoto, et al. "Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report." Journal of neurological surgery reports vol. 75,1 (2014): e62-6. doi: https://doi.org/10.1055/s-0033-1363505
Sakai N, Ito-Yamashita T, Takahashi G, Baba S, Koizumi S, Yamasaki T, Tokuyama T, Namba H. Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness: a case report. J Neurol Surg Rep. 2014 Aug;75(1):e62-6. doi: 10.1055/s-0033-1363505. Epub 2014 Jan 16. PMID: 25083392; PMCID: PMC4110151.
Copy Download .nbib Format: NLM
Rituximab-Induced Acute ST Elevation Myocardial Infarction.

The Ochsner journal

Keswani AN, Williams C, Fuloria J, Polin NM, Jahangir E.
PMID: 26130984
Ochsner J. 2015;15(2):187-90.

BACKGROUND: Rituximab has rarely been associated with acute coronary syndrome (ACS). We report the case of a patient in whom rituximab, a monoclonal antibody used to treat lymphomas of B-cell origin, induced ST elevation myocardial infarction.CASE REPORT: A 46-year-old...

Cite
Keswani AN, Williams C, Fuloria J, et al. Rituximab-Induced Acute ST Elevation Myocardial Infarction. Ochsner J. 2015;15(2):187-90
Keswani, A. N., Williams, C., Fuloria, J., Polin, N. M., & Jahangir, E. (2015). Rituximab-Induced Acute ST Elevation Myocardial Infarction. The Ochsner journal, 15(2), 187-90.
Keswani, Amit N, et al. "Rituximab-Induced Acute ST Elevation Myocardial Infarction." The Ochsner journal vol. 15,2 (2015): 187-90.
Keswani AN, Williams C, Fuloria J, Polin NM, Jahangir E. Rituximab-Induced Acute ST Elevation Myocardial Infarction. Ochsner J. 2015;15(2):187-90. PMID: 26130984; PMCID: PMC4482563.
Copy Download .nbib Format: NLM
Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.

Experimental hematology & oncology

Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A, Gabrielli A, Pomponio G.
PMID: 25671135
Exp Hematol Oncol. 2015 Jan 14;4(1):3. doi: 10.1186/2162-3619-4-3. eCollection 2015.

BACKGROUND: Castleman-Kojima disease (TAFRO Syndrome) is characterized by Thrombocytopenia, Anasarca, myeloFibrosis, Renal dysfunction, Organomegaly, multiple lymphadenopathy and histopathology pattern of atypical Castleman's disease (CD). Only few cases of this recently identified unique variant of Multicentric CD (MCD) are described...

Cite
Tedesco S, Postacchini L, Manfredi L, et al. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol. 2015;4(1):3doi: 10.1186/2162-3619-4-3.
Tedesco, S., Postacchini, L., Manfredi, L., Goteri, G., Luchetti, M. M., Festa, A., Gabrielli, A., & Pomponio, G. (2015). Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Experimental hematology & oncology, 4(1), 3. https://doi.org/10.1186/2162-3619-4-3
Tedesco, Silvia, et al. "Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report." Experimental hematology & oncology vol. 4,1 (2015): 3. doi: https://doi.org/10.1186/2162-3619-4-3
Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A, Gabrielli A, Pomponio G. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol. 2015 Jan 14;4(1):3. doi: 10.1186/2162-3619-4-3. eCollection 2015. PMID: 25671135; PMCID: PMC4322808.
Copy Download .nbib Format: NLM
Eosinophilic Pneumonia in a Patient with Ulcerative Colitis.

Radiology case reports

Patel KB, Robbins MM, Simon ML, Amorosa JK.
PMID: 27303487
Radiol Case Rep. 2015 Dec 07;2(4):49. doi: 10.2484/rcr.2007.v2i4.49. eCollection 2007.

We present the case of 16-year-old woman with a 2-month history of ulcerative colitis who presented with cough, fever, dyspnea on exertion, and nasal congestion. Computed tomography of the chest demonstrated peripheral alveolar opacities with relative sparing of the...

Cite
Patel KB, Robbins MM, Simon ML, et al. Eosinophilic Pneumonia in a Patient with Ulcerative Colitis. Radiol Case Rep. 2015;2(4):49doi: 10.2484/rcr.2007.v2i4.49.
Patel, K. B., Robbins, M. M., Simon, M. L., & Amorosa, J. K. (2007). Eosinophilic Pneumonia in a Patient with Ulcerative Colitis. Radiology case reports, 2(4), 49. https://doi.org/10.2484/rcr.2007.v2i4.49
Patel, Keyur B, et al. "Eosinophilic Pneumonia in a Patient with Ulcerative Colitis." Radiology case reports vol. 2,4 (2007): 49. doi: https://doi.org/10.2484/rcr.2007.v2i4.49
Patel KB, Robbins MM, Simon ML, Amorosa JK. Eosinophilic Pneumonia in a Patient with Ulcerative Colitis. Radiol Case Rep. 2015 Dec 07;2(4):49. doi: 10.2484/rcr.2007.v2i4.49. eCollection 2007. PMID: 27303487; PMCID: PMC4896014.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Chebane L, Tavassoli N, Bagheri H, Jean-LouisMontastruc.
PMID: 27393246
Therapie. 2010 Sep-Oct;65(5):447-58. doi: 10.2515/therapie/2010051.

OBJECTIVE: To analyse drugs inducing hyperglycemia by using data reported to the French spontaneous reporting system and recorded in the French PharmacoVigilance Database (FPVD).METHODS: All cases with a report of hyperglycemia and/or diabetes in the French database between 1985...

Cite
Chebane L, Tavassoli N, Bagheri H, et al. Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie. 2010;65(5):447-58doi: 10.2515/therapie/2010051.
Chebane, L., Tavassoli, N., Bagheri, H., Jean-LouisMontastruc. (2010). Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie, 65(5), 447-58. https://doi.org/10.2515/therapie/2010051
Chebane, Leila, et al. "Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV)." [Not Available]. Therapie vol. 65,5 (2010): 447-58. doi: https://doi.org/10.2515/therapie/2010051
Chebane L, Tavassoli N, Bagheri H, Jean-LouisMontastruc. Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie. 2010 Sep-Oct;65(5):447-58. doi: 10.2515/therapie/2010051. French. PMID: 27393246.
Copy Download .nbib Format: NLM
Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia

Maliekel K, Rana N, Green D.
PMID: 27214621
Haemophilia. 1997 Jan;3(1):54-8. doi: 10.1046/j.1365-2516.1997.00075.x.

Bleeding in nonhaemophilic patients with high-titre factor VIII autoantibodies is often severe, life-threatening and refractory to treatment with factor VIII concentrates. In this report, we describe an elderly woman who required surgical excision of a large haemophilic pseudotumour adjacent...

Cite
Maliekel K, Rana N, Green D. Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia. Haemophilia. 1997;3(1):54-8doi: 10.1046/j.1365-2516.1997.00075.x.
Maliekel, K., Rana, N., & Green, D. (1997). Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia, 3(1), 54-8. https://doi.org/10.1046/j.1365-2516.1997.00075.x
Maliekel, K, et al. "Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia." Haemophilia : the official journal of the World Federation of Hemophilia vol. 3,1 (1997): 54-8. doi: https://doi.org/10.1046/j.1365-2516.1997.00075.x
Maliekel K, Rana N, Green D. Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia. Haemophilia. 1997 Jan;3(1):54-8. doi: 10.1046/j.1365-2516.1997.00075.x. PMID: 27214621.
Copy Download .nbib Format: NLM
Bleomycin-induced flagellate dermatitis.

Revista brasileira de hematologia e hemoterapia

Mota GD, Penna AM, Soares RC, Baiocchi OC.
PMID: 25031171
Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):297-9. doi: 10.1016/j.bjhh.2014.03.001. Epub 2014 Apr 03.

A 29-year-old woman with stage IVB Hodgkin's lymphoma was treated with doxorubicin, bleomycin, vinblastine, and dacarbazine. Two weeks after the first cycle was completed, she developed pruritic, linear erythematous lesions in a flagellate-like pattern on the trunk, neck and...

Cite
Mota GD, Penna AM, Soares RC, et al. Bleomycin-induced flagellate dermatitis. Rev Bras Hematol Hemoter. 2014;36(4):297-9doi: 10.1016/j.bjhh.2014.03.001.
Mota, G. D., Penna, A. M., Soares, R. C., & Baiocchi, O. C. (2014). Bleomycin-induced flagellate dermatitis. Revista brasileira de hematologia e hemoterapia, 36(4), 297-9. https://doi.org/10.1016/j.bjhh.2014.03.001
Mota, Guilherme Devidé, et al. "Bleomycin-induced flagellate dermatitis." Revista brasileira de hematologia e hemoterapia vol. 36,4 (2014): 297-9. doi: https://doi.org/10.1016/j.bjhh.2014.03.001
Mota GD, Penna AM, Soares RC, Baiocchi OC. Bleomycin-induced flagellate dermatitis. Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):297-9. doi: 10.1016/j.bjhh.2014.03.001. Epub 2014 Apr 03. PMID: 25031171; PMCID: PMC4207924.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2623 entries